Prevalence and Temporal Trends of Mental Disorders in Persons with Opioid Use Disorder and Concurrent Mental Disorders in British Columbia, Canada, Using Population-Level Administrative Data, 2013 to 2021: Prévalence et tendances temporelles des troubles mentaux chez les personnes souffrant d’un trouble lié à la consommation d’opioïdes et de troubles mentaux concomitants en Colombie-Britannique, au Canada, à partir de données administratives au niveau de la population, entre 2013 et 2021
Angela Russolillo, Fahmida Homayra, Bohdan Nosyk

TL;DR
This study shows that mental disorders are common among people with opioid use disorder in British Columbia, and their rates have increased significantly from 2013 to 2021.
Contribution
The study provides the first population-level analysis of mental disorder prevalence and trends among individuals with opioid use disorder in British Columbia.
Findings
Anxiety disorders were the most common mental disorder among individuals with opioid use disorder (91.7%).
The annual period prevalence of any mental disorder increased by 7.0% per year from 2013 to 2021.
Males had a higher annual age-standardized prevalence of mental disorders compared to females.
Abstract
Opioid use is a major public health issue and associated with a broad range of comorbid mental disorders. Globally, there is considerable variability in reported rates of mental disorders among individuals with opioid use disorder (OUD), limiting timely intervention and evidence-based treatment among this population. We estimate the prevalence of specific mental disorders among individuals with a concurrent OUD using population-level administrative data in British Columbia, Canada. A population-based retrospective observational study using individual-level linked health administrative data in British Columbia, Canada. Individuals with an OUD and concurrent mental disorder between January 1, 2013, and August 31, 2021, were included and followed from their first indication of OUD until censoring (death, administrative loss to follow-up, or August 31, 2021). We reported annual period…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsOpioid Use Disorder Treatment · Bipolar Disorder and Treatment · Schizophrenia research and treatment
